Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: Post hoc analysis of the ALERT study

Clinical Transplantation

Volumn 20, Issue 3, 2006, Pages 374-382

  Øien, Cecilia Montgomery ^a,b   Reisæter, Anna Varberg ^c   Os, Ingrid ^a,d   Jardine, Alan ^e   Fellström, Bengt ^f   Holdaas, Hallvard ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular disease; Gender; Mortality; Renal transplantation; Risk factor analysis

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; COUMARIN; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRATE; PREDNISOLONE; TRIACYLGLYCEROL; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GENDER; HEART DEATH; HEART INFARCTION; HEART PROTECTION; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33745065841     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00496.x     Document Type: Article

References (20)

1. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease. A prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 1999: 99: 1165.
2. Foley RN, Parfrey PS, Saranak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998: 32: S112.
3. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port F. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000: 57: 307.
4. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000: 11: 1735.
5. Muntner P, Jiang H, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002: 13: 745.
6. Meier-Kriesche H-U, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003: 75: 1291.
7. Holdaas H, Fellström B, Jardine AG et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial. Lancet 2003: 361: 2024.
8. Jungers P, Massy ZA, Khoa TN et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 1997: 12: 2597.
9. Aakhus S, Dahl K, Widerøe TE. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 1999: 14: 648.
10. Bittner V. Lipoprotein abnormalities related to women's health. Am J Cardiol 2002: 90 (Suppl.): 77i.
11. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005: 16: 496.
12. Woo YM, Mclean D, Kavavagh D et al. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation. J Nephrol 2002: 15: 380.
13. Rigatto C, Foley RN, Kent GM, Guttmann R, Parfrey PS. Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation 2000: 70: 570.
14. Shai I, Rimm EB, Hankinson SE. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women. Circulation 2004: 110: 2284.
15. Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol 2005: 45: 1413.
16. Mann JFE, Gerstein HC, Dulau-Florea I, Lonn E. Cardiovascular risk in patients with mild renal insufficiency. Kidney Int 2003: 63: S192.
17. Fellström B, Jardine AG, Soveri I et al. Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. Am J Transplant 2005: 8: 1986.
18. Cosio FG, Alamir A, Yim S. Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 1998: 53: 767.
19. Rothwell PM. Subgroup analysis in randomized controlled trials: importance, indications, and interpretation. Lancet 2005: 365: 176.
20. Stampfer MJ, Frank BH, Manson JAE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000: 343: 16.